Oraverse Versus Laser (RCT)

sara nabil

Status and phase: Enrolling; Phase 3

Conditions: Reversal of Local Anesthesia in Children

Treatments: Device: diode laser; Drug: OraVerse Injectable Product

Study type: Interventional

Funder types: Other

Identifiers

NCT05473858

AlAzhar

Details and patient eligibility

About

clinically assess the reversal of articaine 4% of two different concentration of vasoconcentration soft-tissue local anesthesia in pediatric dentistry using Diode Laser and Oraverse

Full description

Patients will be divided randomly into two groups (20 patients in each group) Group (1): Patients will be undergoing anesthesia revision by diode laser Group (2): Patients will be undergoing anesthesia revision by oraverse. Then each group will be subdivided into 2 subgroups (10 patients each) according to type of local anesthetic agent into:

subgroup 1: Articaine 4% with 1:100000 epinephrin &Subgroup 2: Articaine 4% with 1:200000 epinephrin After 30 min of injection corresponding to approximate time of treatment, the patient in each group will be exposed to the reversal agent which may be diode laser or oraverse.

Enrollment: 40 estimated patients

Sex: All

Ages: 6 to 10 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. Patients who need to be treated under anesthesia by injecting mandibular first molar infiltration.
2. Cooperative children aged 6 to 10 years old with the ability to understand and respond to the sensation of soft tissue -

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

40 participants in 2 patient groups

laser group

Experimental group

Description:

Patients will be undergoing anesthesia revision by diode laser

Treatment:

Device: diode laser

oraverse group

Experimental group

Description:

Patients will be undergoing anesthesia revision by oraverse

Treatment:

Drug: OraVerse Injectable Product